AGRX
Agile Therapeutics, Inc
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
21 hedge funds and large institutions have $496K invested in Agile Therapeutics, Inc in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
5
Increased
7
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$115K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$39.9K |
3 |
AC
3
Armistice Capital
New York
|
$211K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$37.5K |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$15K |
Top Sellers
1 |
1
BlackRock
New York
|
$11.2K |
2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$26.8K |
3 |
![]()
3
Fidelity Investments
Boston,
Massachusetts
|
$0 |
4 |
4
Osaic Holdings
Scottsdale,
Arizona
|
$7 |